Scientific topics
Keywords
Patrick Blader DPhil (Oxford) Developmental Molecular Genetics
Course and current status
Present Position
Directeur de recherches at INSERM.
Principle Investigator
Centre de Biologie du Développement (CBD, UMR5547)
Centre de Biologie Integrative de Toulouse (CBI, FR 3743)
Université Paul Sabatier, Toulouse III
118, route de Narbonne, 31062 TOULOUSE
Research Experience
September 2001 - December 2010
Chargé de recherches (CR1) at INSERM.
Principle Investigator
Centre de Biologie du Développement UMR5547
Université Paul Sabatier, Toulouse III
118, route de Narbonne, 31062 TOULOUSE
September 1998 - August 2001:
Chargé de Recherche (CR1) at INSERM
Institut de Génétique et de Biologie Moléculaire et Cellulaire
Illkirch, CU de Strasbourg, France
September 1995 - August 1998:
Postdoctoral Fellow
Institut de Génétique et de Biologie Moléculaire et Cellulaire
Illkirch, CU de Strasbourg, France
September 1990 - August 1995:
Doctoral Student
ICRF Developmental Biology Unit
Department of Zoology
University of Oxford, UK
Scientific summary
I am the Principal Investigator of a research team founded under the "ACI Jeune Chercheur programme" in 2001. As of January 2017, the group is composed of 9 people including myself and 3 CR1 (CNRS Staff Scientists), 1 Professor (UPS), 3 PhD students (MRT, Chinese Scholarship Council, ANR CDD) et 1 Post-doctoral fellow (FRM CDD). Recent ANR funding will permit us to add either a Post-doctoral fellow, PhD student or technician early in 2017 depending on what we believe will be the most appropriate for the project.
My research team is principally interested in understanding the molecular mechanisms underlying the development of the nervous system. Our research model is the zebrafish embryo. Team projects include how left/right asymmetry is established in the brain, how pineal photoreceptor subtypes are specified and how these subtype regulate district behaviors and how neurogenesis and morphogenesis are coordinated during development of the olfactory placode. More recently, we have embarked on a collaboration with a human geneticist in Paris to model Diamond-Blackfan Anemia – a ribosomopathy.
